Customer group: Guest | You do not have the permission to see the prices, please create an account.
Welcome back!

Omalizumab / Xolair®

Drug name: Xolair®

INN: Omalizumab

API type: Omalizumab is a humanised monoclonal antibody manufactured by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell line.

Pharmacotherapeutic group: Drugs for obstructive airway diseases, other systemic drugs for obstructive airway diseases

ATC code: R03DX05

General function:

Short description:

Original license holder:

Marketing authorisation numbers: EU/1/05/319/001 - 010

Marketing authorisation holder: Novartis Europharm Limited; Frimley Business Park; Camberley GU16 7SR; United Kingdom

Name of the manufacturer of the biological active substance: Novartis Pharma S.A.S.; Centre de Biotechnologie; 8, rue de l’Industrie; F-68330 Huningue; France

Name and address of the manufacturer responsible for batch release: Novartis Pharma GmbH; Roonstrasse 25; D-90429 Nuremberg; Germany

Max shelf life: 48 months

Storage conditions: 2°C – 8°C

List of excipients: Powder: Sucrose, L-histidine, L-histidine hydrochloride monohydrate, Polysorbate 20
Solvent: Water for injections